InsiderTrades.com logo

LLAI Insider Trading

Insider Ownership Percentage: 48.41%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

LungLife AI Insider Trading History Chart

This chart shows the insider buying and selling history at LungLife AI by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LungLife AI Share Price & Price History

Current Price: GBX 3.50
Price Change: ▼ Price Decrease of -0.75 (-17.65%)
As of 05/28/2025 12:58 PM ET

This chart shows the closing price history over time for LLAI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

LungLife AI Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/14/2023Paul Carmelo PaganoInsiderBuy12,123GBX 70£8,486.10
See Full Table

SEC Filings (Institutional Ownership Changes) for LungLife AI (LON:LLAI)

42.50% of LungLife AI stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

LungLife AI is a developer of clinical diagnostic solutions designed to make a significant impact in the early detection of lung cancer, the deadliest cancer globally. Using a minimally invasive blood draw, the Company's LungLB® test is designed to deliver additional information to clinicians who are evaluating indeterminate lung nodules. For more information visit www.lunglifeai.com Our Purpose is to be a driving force in the early detection to lung cancer. Our Vision is to invert the 20:80 ratio such that in years to come at least 80% of lung cancer is detected early.
Read More on LungLife AI

Today's Range

Now: GBX 3.50
Low: 3.14
High: 5

50 Day Range

MA: GBX 3.50
Low: 3.50
High: 3.50

52 Week Range

Now: GBX 3.50
Low: 0.80
High: 21.70

Volume

1,681,295 shs

Average Volume

449,541 shs

Market Capitalization

£1.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A